Global framework for biosimilars "is now crucial"

Article Date: 25/04/2012 06:00
Global framework for biosimilars "is now crucial"

Vacancy Search

Quick job search

Advanced Search

Latest News

Earlier start for new GSK chairman Hampton

Earlier start for new GSK chairman Hampton

Japan hits Novartis with 15-day ban over side effect reports

Japan hits Novartis with 15-day ban over side effect reports

AMR review head O'Neill calls for $2 billion innovation fund

AMR review head O'Neill calls for $2 billion innovation fund

Bigger is better for Sorin-Cyberonics combination

The starting gun on the medtech M&A derby of 2015 fired yesterday with the tie-up of the US-based Cyberonics and Italian company Sorin, a combination that should offer bargain-hunting...

Upcoming events: pacritinib in myelofibrosis and an adcom for Kythera

Welcome to your weekly digest of approaching regulatory and clinical readouts. By the end of the first quarter CTI Biopharma is expected to report topline phase III results of pacritinib in...

Boehringer puts BACE inhibitor trial on hold

Boehringer puts BACE inhibitor trial on hold

EMA will review Amgen/Onyx' myeloma drug

EMA will review Amgen/Onyx' myeloma drug

New indication for Bayer/Regeneron's Eylea in EU

New indication for Bayer/Regeneron's Eylea in EU

Newron Parkinson's drug Xadago gets Europe okay

Newron Parkinson's drug Xadago gets Europe okay

NICE backs biologics for ulcerative colitis

NICE backs biologics for ulcerative colitis
more news